[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100549128":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":34,"centralContacts":38,"locations":45,"responsibleParty":68,"collaborators":42,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":42,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":42,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":42,"overallStatus":48,"whyStopped":42,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Children's National Research Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexamethasone group","ACTIVE_COMPARATOR","Dexamethasone five days with 0.6 mg\u002F kg dose per day max 16 mg dose. Standard care will also be provided.",[13],"Drug: Dexamethasone",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo group","PLACEBO_COMPARATOR","Placebo for five days with one dose per day placebo oral dosing. Standard care will also be provided.",[19],"Drug: Placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Dexamethasone","Steroid five day treatment",[9],[27],"DexPak",{"type":22,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Placebo","Placebo control group",[15],[33],"Sugar Pill",[35],{"name":36,"affiliation":5,"role":37},"Natasha Shur, MD","PRINCIPAL_INVESTIGATOR",[39,44],{"name":36,"role":40,"phone":41,"phoneExt":42,"email":43},"CONTACT","202-476-5000",null,"nshur2@childrensnational.org",{"name":36,"role":40,"phone":42,"phoneExt":42,"email":43},[46],{"facility":47,"status":48,"city":49,"state":50,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Childrens National","RECRUITING","Washington D.C.","District of Columbia","20010","United States","US",{"type":55,"coordinates":56},"Point",[57,58],-77.03637,38.89511,{"lat":58,"lon":57},[61,64],{"name":62,"role":40,"phone":63,"phoneExt":42,"email":43},"Natasha Shur","202 545-2515",{"name":65,"role":40,"phone":66,"phoneExt":42,"email":67},"Seth Berger","202 476-6156","sberger@childrensnational.org",{"type":37,"investigatorFullName":62,"investigatorTitle":69,"investigatorAffiliation":5,"oldNameTitle":42,"oldOrganization":42},"MD, Principal Investigator, Professor","100549128","phase-1-dexamethasone-use-in-pediatric-rhabdomyolysis-patients-in-addition-to-standard-protocols-100549128",false,"NCT06429982","Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols","A Clinical Trial to Assess Whether Dexamethasone Addition to Standard Protocols for Non-Traumatic Rhabdomyolysis of Unknown or Genetic Etiologies Improves Patient Outcomes","Inclusion Criteria\n\n1. Diagnosis of rhabdomyolysis defined as creatine kinase\\> 5000 with trauma excluded\n2. Ability of parents\u002Fpatients to understand and the willingness to sign a written informed consent document.\n3. Patients ages 12 and older will sign written assent\n\nExclusion Criteria:\n\n* Already taking systemic steroids.\n* Inability to comply with study instructions.\n* Uncontrolled intercurrent illness or psychiatric illness\u002Fsocial situations that would limit compliance with study requirements.\n* Pregnant women.\n\n  o A urine pregnancy test will be performed for women of child-bearing potential.\n* Below gestational age of 40 weeks\n* Allergy to fluconazole, clotrimazole or nystatin.\n* Cannot tolerate PO medications","ALL","6 Months","25 Years",{"count":81,"type":82},50,"ESTIMATED","INTERVENTIONAL",[85],"PHASE1","There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic study has not yet been initiated, and steroids have not been yet considered in as a consideration to standard care guidelines.\n\nThe hypothesis is that patients who receive dexamethasone in addition to standard care versus placebo and standard care will have improvement in pain, length of hospital stay, and decrease in kidney complications.",[88],"Rhabdomyolysis","2025-07-01",{"date":91,"type":92},"2025-07-03","ACTUAL",{"date":94,"type":92},"2024-10-01",{"date":96,"type":82},"2026-12-31",{"name":5,"class":6},1]